Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build Kenya flag

Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions

CodeSystem: Kenya Cancer Primary Site Code System

Official URL: https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs Version: 0.1.0
Active as of 2026-06-04 Computable Name: CancerPrimarySiteCS

Codes for the anatomical primary site of a malignancy, aligned with ICD-10 topography.

This Code system is referenced in the definition of the following value sets:

This case-sensitive code system https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs defines the following codes:

CodeDisplayDefinition
BREAST Breast C50 — Malignant neoplasm of breast.
CERVIX-UTERI Cervix Uteri C53 — Malignant neoplasm of cervix uteri.
CORPUS-UTERI Corpus Uteri C54 — Malignant neoplasm of corpus uteri.
OVARY Ovary C56 — Malignant neoplasm of ovary.
PROSTATE Prostate C61 — Malignant neoplasm of prostate.
COLON Colon C18 — Malignant neoplasm of colon.
RECTUM Rectum C20 — Malignant neoplasm of rectum.
OESOPHAGUS Oesophagus C15 — Malignant neoplasm of oesophagus.
STOMACH Stomach C16 — Malignant neoplasm of stomach.
LIVER Liver and Intrahepatic Ducts C22 — Malignant neoplasm of liver.
PANCREAS Pancreas C25 — Malignant neoplasm of pancreas.
LUNG Lung and Bronchus C34 — Malignant neoplasm of bronchus and lung.
LARYNX Larynx C32 — Malignant neoplasm of larynx.
NASOPHARYNX Nasopharynx C11 — Malignant neoplasm of nasopharynx.
ORAL-CAVITY Oral Cavity and Pharynx C00–C14 — Malignant neoplasm of lip, oral cavity and pharynx.
THYROID Thyroid Gland C73 — Malignant neoplasm of thyroid.
KIDNEY Kidney C64 — Malignant neoplasm of kidney.
BLADDER Urinary Bladder C67 — Malignant neoplasm of bladder.
SKIN-MELANOMA Skin — Melanoma C43 — Malignant melanoma of skin.
SKIN-NON-MELANOMA Skin — Non-melanoma C44 — Other malignant neoplasms of skin.
BRAIN-CNS Brain and CNS C71–C72 — Malignant neoplasm of brain / CNS.
BONE Bone and Articular Cartilage C40–C41 — Malignant neoplasm of bone.
SOFT-TISSUE Soft Tissue / Sarcoma C49 — Malignant neoplasm of connective and soft tissue.
BURKITT-LYMPHOMA Burkitt Lymphoma C83.7 — Burkitt lymphoma.
HODGKIN-LYMPHOMA Hodgkin Lymphoma C81 — Hodgkin lymphoma.
NON-HODGKIN-LYMPHOMA Non-Hodgkin Lymphoma C82–C86 — Non-Hodgkin lymphoma.
LEUKAEMIA-ALL Leukaemia — ALL C91.0 — Acute lymphoblastic leukaemia.
LEUKAEMIA-AML Leukaemia — AML C92.0 — Acute myeloid leukaemia.
LEUKAEMIA-CLL Leukaemia — CLL C91.1 — Chronic lymphocytic leukaemia.
LEUKAEMIA-CML Leukaemia — CML C92.1 — Chronic myeloid leukaemia.
MULTIPLE-MYELOMA Multiple Myeloma C90.0 — Multiple myeloma.
KAPOSI-SARCOMA Kaposi Sarcoma C46 — Kaposi sarcoma.
WILMS-TUMOUR Wilms Tumour (Nephroblastoma) C64 — Malignant neoplasm of kidney (paediatric).
RETINOBLASTOMA Retinoblastoma C69.2 — Retinoblastoma.
OTHER Other / Not Specified Primary site not listed or not specified.

Description of the above table(s).